CEMP

Cempra

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Melinta Therapeutics, Inc. market cap is $129.17M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Melinta Therapeutics, Inc. 52 week high is $24.25 as of October 24, 2025.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Melinta Therapeutics, Inc. 52 week low is $10.25 as of October 24, 2025.

Melinta Therapeutics, Inc. stock price today is $2.35.

Melinta Therapeutics, Inc. stock price yesterday was $2.30.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Melinta Therapeutics, Inc.’s P/E ratio is None.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Melinta Therapeutics, Inc. P/B ratio is 0.8998.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Melinta Therapeutics, Inc.'s EBITDA is N/A.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Melinta Therapeutics, Inc. 50-day moving average is $15.42.

Melinta Therapeutics, Inc. has 45 employees.